Ironwood Pharmaceuticals
IRWD
140 hedge funds and large institutions have $1.71B invested in Ironwood Pharmaceuticals in 2014 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 45 increasing their positions, 35 reducing their positions, and 17 closing their positions.
29% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 35
12% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 17
1% more funds holding
Funds holding: 138 → 140 (+2)
12% less capital invested
Capital invested by funds: $1.93B → $1.71B (-$226M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
58% less call options, than puts
Call options by funds: $3.06M | Put options by funds: $7.37M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$92.6M |
| 2 |
O
OrbiMed
New York
|
+$42M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$19.9M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$17.7M |
| 5 |
Asset Management One
Tokyo,
Japan
|
+$12.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$49.4M |
| 2 |
Millennium Management
New York
|
-$27.8M |
| 3 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
-$24.8M |
| 4 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
-$11.8M |
| 5 |
TCM
Tamarack Capital Management
Carlsbad,
California
|
-$11.5M |
IRWD Hedge Fund Activity: Q3 2014 in Review
140 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in Ironwood Pharmaceuticals (IRWD) for Q3 2014, worth a combined $1.71B — down 12% from $1.93B a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new IRWD positions and 17 closed out — a net gain of 2 holders — while 45 added to existing stakes and 35 trimmed.
The largest buyer was Janus Henderson Investors US, adding an estimated $92.6M. The largest seller was BVF Inc, cutting an estimated $49.4M.
- 140 institutional investors held Ironwood Pharmaceuticals (IRWD) as of Q3 2014, up from 138 in Q2 2014.
- Funds reported $1.71B of Ironwood Pharmaceuticals stock for Q3 2014, down 12% quarter-over-quarter.
- 19 funds opened new Ironwood Pharmaceuticals positions in Q3 2014 and 17 closed out, a net change of +2 holders.
- The largest Ironwood Pharmaceuticals buyer in Q3 2014 was Janus Henderson Investors US, an estimated $92.6M added.
- The largest Ironwood Pharmaceuticals seller in Q3 2014 was BVF Inc, an estimated $49.4M sold.
Based on aggregated 13F filings for Q3 2014.